Relapsing polychondritis after COVID-19 vaccination.

Ito, Koki; Ogawa, Takunori; Igarashi, Shunya; Miyai, Kosuke; Sato, Kimiya; Kawana, Akihiko; Kimizuka, Yoshifumi

Ito, Koki; Ogawa, Takunori; Igarashi, Shunya; Miyai, Kosuke; Sato, Kimiya; Kawana, Akihiko; Kimizuka, Yoshifumi.

Afiliación

Ito K; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine National Defense Medical College Saitama Japan.
Ogawa T; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine National Defense Medical College Saitama Japan.
Igarashi S; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine National Defense Medical College Saitama Japan.
Miyai K; Department of Pathology and Laboratory Medicine National Defense Medical College Saitama Japan.
Sato K; Department of Basic Pathology National Defense Medical College Saitama Japan.
Kawana A; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine National Defense Medical College Saitama Japan.
Kimizuka Y; Division of Infectious Diseases and Respiratory Medicine, Department of Internal Medicine National Defense Medical College Saitama Japan.

Respirol Case Rep ; 12(9): e70008, 2024 Sep.

Article en En | MEDLINE | ID: mdl-39220095

ABSTRACT

ABSTRACT

Relapsing polychondritis (RP) is a rare inflammatory disorder involving immune-mediated destruction of cartilaginous structures. Herein, we present the first report of a strong association between COVID-19 vaccination and RP development. Clinicians should be aware that RP is among the autoimmune diseases that can develop after mRNA vaccination.

Palabras clave

COVID19; relapsing polychondritis; vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Respirol Case Rep Año: 2024 Tipo del documento: Article